Strides Pharma Schedules Q2FY27 Earnings Conference Call for 30th Oct'26
Strides Pharma Science Ltd 路 Intimation 路 30 Oct 2026, 10:00 am
Strides Pharma Schedules Q2FY27 Earnings Conference Call for 30th Oct'26 Strides Pharma Science Limited will host an earnings conference call for investors and analysts on 30th Oct'26 at 10:00 AM IST to discuss its unaudited financial results for the quarter and half-year ended 30th Sep'26 (Q2FY27). Key management participants include Managing Director & Group CEO Badree Komandur and Group CFO Vikesh Kumar. Dial-in access is available across major regions, including India, the US, the UK, Singapore, and Hong Kong.
Original exchange filing (PDF)
More announcements from Strides Pharma Science Ltd
- Transcript of Earnings Call pertaining of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 路 02 Nov 2026
- Audio Recording of Earnings Call pertaining to unaudited Financial Results for the quarter and half year ended September 30, 2026 路 30 Oct 2026
- Appointment of Mr. Biren Gabhawala (DIN:03091772) as a Non-Executive Independent Director of the Company with effect from November 1, 2026. 路 30 Oct 2026
- Allotment of Equity shares pursuant to exercise of Stock Options. 路 30 Oct 2026
- Earnings presentation for the quarter and half year ended September 30, 2026. 路 30 Oct 2026
- Strides Delivers Strong Performance with Q2FY27 Revenue at Rs. 14.297m, Grew 17% YoY. Ex-US Markets Up 31% YoY; EBITDA Up 8% YoY to Rs. 2,509m, Crossing Rs. 2,500m in a Quarter for the First Time. 路 30 Oct 2026
- Financial Results for the quarter and half year ended Sept 30, 2026 路 30 Oct 2026
- Strides Pharma Science Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 30 Oct 2026
